Table 4 Clinical features of patients with papillary thyroid cancer by group in patients with and without Hashimoto’s thyroiditis (HT)
Characteristics | Group I | Group II | χ2 | P-value |
|---|---|---|---|---|
(with HT) | (without HT) | |||
n = 187 | n = 817 | |||
Age, yr | 7.298 | 0.063 | ||
<30 | 23 (12.3) | 65 (8.0) | ||
30~44 | 76 (40.6) | 362 (44.3) | ||
45~59 | 74 (39.6) | 291 (35.6) | ||
>60 | 14 (7.5) | 99 (12.1) | ||
Gender | 35.082 | <0.001* | ||
Male | 5 (2.7) | 171 (20.9) | ||
Female | 182 (97.3) | 646 (79.1) | ||
Thyroid-associated disorders | 3.322 | 0.325 | ||
Nodular goiter | 56 (81.2) | 258 (82.2) | ||
Follicular adenoma | 8 (11.6) | 45 (14.3) | ||
Graves disease | 4 (5.8) | 10 (3.2) | ||
Malignant lymphoma | 1 (1.4) | 1 (0.3) |